← Back to Search

No statin for Cardiovascular Disease (ACHIEVE Trial)

N/A
Waitlist Available
Led By Christopher Granger, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Summary

ACHIEVE aims to increase statin usage among patients with ASCVD by having a pharmacist talk to patients and providers.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient engagement as measured by recruitment
Provider engagement as measured by recruitment

Trial Design

1Treatment groups
Experimental Treatment
Group I: No statinExperimental Treatment1 Intervention
Patients who are identified with ASCVD who do not take a statin or do not take the recommended dose.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,424 Previous Clinical Trials
3,065,859 Total Patients Enrolled
Harvard Pilgrim Health CareOTHER
59 Previous Clinical Trials
24,984,473 Total Patients Enrolled
Carelon ResearchOTHER
75 Previous Clinical Trials
218,405 Total Patients Enrolled
~150 spots leftby Jan 2025